☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Arbutus
Arbutus Signs an Exclusive Licensing Agreement with Qilu to Develop and Commercialize AB-729 for the Treatment of Hepatitis B
December 14, 2021
PharmaShots Weekly Snapshot (September 30'October 04, 2019)
October 7, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
